Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

VIDEO: Mine Gold Without Mining? ELY Gold talks Nevada

Want to mine Gold without mining? - Royalty companies receive streams of cash from a business in exchange for cash upfront or land usage — it is relatively easy to understand. They also often pay healthy dividends; which income investors can appreciate. Developing a...
Stockhouse Media | August 28, 2019 |

Focus Graphite is Developing a Mine in a High Demand Resource Sector

Interview with President & COO Don Baxter at the Mines & Money 2014 in London Symbol: V.FMS
Commodity-TV | June 8, 2018 |

Applied Therapeutics Investors Like the ACTION in Phase 2 Galactosemia Study

Applied Therapeutics' shares traded 25% higher today after the company reported positive topline results from its Pivotal Phase 2 ACTION Study of AT-007 for use in the treatment of galactosemia. The firm expects to file for regulatory approval of AT-007 in H2/20. This...
Streetwise Reports | January 9, 2020 |

Pharmaceutical company treats bladder cancer with new tech

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Theralase Technologies Inc. (TSXV:TLT) , a clinical-stage pharmaceutical company, is currently developing an innovative, research-backed technology for the ...
Ryan Dhillon | January 8, 2024 |

Big-Time Communications Play = A Profitable Small-Cap Opportunity

(Click image to play video) The importance of clear, reliable communications cannot be understated. From smartphones to emergency broadband radio transceivers to advanced military / civilian satellite systems…every aspect of our everyday lives is dependent on st...
Dave Jackson | April 6, 2021 |

Navidea Shares Jump 60% on Phase 2b Rheumatoid Arthritis Trial Results

Shares of Navidea Biopharmaceuticals traded 60% higher today on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study. Developer of precision immunodiagnostic agents and immunotherape...
Streetwise Reports | October 30, 2019 |

How To Invest In Cannabis Stocks

Over the last few years, the cannabis sector has been the place to be for stock investors. It is undoubtedly one of the hottest markets around, with a May 2019 report expecting the cannabis market to be worth USD $66.3 billion by 2025 . At the same time, investing in a ...
Stockhouse Editorial | July 29, 2019 |

Buzz on the Bullboards: Staying healthy

From short-term health care bets to long-term energy plays, and the swings of the cannabis market, small-cap investors have had their hands full keeping up with the markets in 2023. A recent merger among top names in cannabis hit the health care market hard this...
Jonathon Brown | April 13, 2023 |

Arbutus Biopharma Trades 25% Higher on Phase 1 Hepatitis B Results

Shares of Arbutus Biopharma traded higher after the company reported significant and continuous reduction in HBsAg in 12 chronic hepatitis B subjects using 60 mg dosage of its AB-729 drug. Clinical-stage biopharmaceutical company Arbutus Biopharma Corp. (ABUS:NASD...
Streetwise Reports | May 20, 2020 |

Bonanza-Grade Gold-Silver Discovery is a Real “Jewel”

Meet the Company and its CEO that are exploring for gold, silver, and copper in some of North America’s most resource-friendly, prolific, and historic mining districts…and with some recent eye-popping results. Golden Lake Exploration Inc. (GLM) ( CSE.GLM...
Dave Jackson | March 19, 2021 |
1 2 3 4 5 6 7 8 9 10 ...